SEC EDGAR Filing Information

Form 8-K -- Current report

Period of Report: 2007-11-30
Filing Date Changed: 2007-12-03
Documents: 2

SEC Accession No.
0001193125-07-258186
Filing date: 2007-12-04
Accepted: 2007-12-03 19:46:39

Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Table of submitted documents:

Seq	Type	Document	Size	Description
1	8-K	d8k.htm	12470	FORM 8-K
2	EX-10.1	dex101.htm	57866	AMENDMENT NO.6 TO THE CREDIT AGREEMENT DATED AS OF AUGUST 20, 2004

		0001193125-07-258186.txt	72514	Complete submission text file

Filer Information:

US ONCOLOGY INC (Filer) (0000943061)
IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26190 | Film No.: 071281821
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

Assistant Director 1

Business Address
16825 NORTHCHASE DR
STE 1300
HOUSTON TX 77060
2818732674

Mailing Address

US Oncology Holdings, Inc. (Filer) (0001333191)
IRS No.: 200873619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-126922 | Film No.: 071281820
SIC: 8060 Services-Hospitals

Assistant Director 1

Business Address
16825 NORTHCHASE DRIVE, SUITE 1300
HOUSTON TX 77060
(832) 601-8766

Mailing Address
16825 NORTHCHASE DRIVE, SUITE 1300
HOUSTON TX 77060